Targeting Myeloid-Derived Suppressor Cells (Mdscs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (Pd-1)- Blockade Immunotherapy against Cancers

2019-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/689448Targeting Myeloid-Derived Suppressor Cells (Mdscs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (Pd-1)- Blockade Immunotherapy against Cancers